BioSyent Inc.
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (5)
Compared with Healthcare companies in Canada.
P/E ratio
19.6Investors pay 19.6 for every 1 of BioSyent Inc.'s yearly profit, higher than 50% of Healthcare companies in Canada.
P/B ratio
4.09The share price is 4.09 times BioSyent Inc.'s book value per share, higher than 68% of Healthcare companies in Canada.
Market cap
C$187 MThe total market value of all of BioSyent Inc.'s shares at today's price (share price × number of shares), larger than 74% of Healthcare companies in Canada. PosiCap size class: Mini Cap.
Return on equity (ROE)
23.6%BioSyent Inc. earned 23.6% on its shareholders' money over the last year, higher than 92% of Healthcare companies in Canada.
Dividend yield
1.32%BioSyent Inc. pays 1.32% of its share price as dividends a year.
Questions
What is BioSyent Inc.'s P/E ratio?
Investors pay 19.6 for every 1 of BioSyent Inc.'s yearly profit, higher than 50% of Healthcare companies in Canada.
What is BioSyent Inc.'s return on equity?
BioSyent Inc. earned 23.6% on its shareholders' money over the last year, higher than 92% of Healthcare companies in Canada.
Does BioSyent Inc. pay a dividend?
Yes. BioSyent Inc. pays 1.32% of its share price as dividends a year.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.